Cargando…
A case of fatal Type I congenital disorders of glycosylation (CDG I) associated with low dehydrodolichol diphosphate synthase (DHDDS) activity
BACKGROUND: Type I congenital disorders of glycosylation (CDG-I) are mostly complex multisystemic diseases associated with hypoglycosylated serum glycoproteins. A subgroup harbour mutations in genes necessary for the biosynthesis of the dolichol-linked oligosaccharide (DLO) precursor that is essenti...
Autores principales: | Sabry, S., Vuillaumier-Barrot, S., Mintet, E., Fasseu, M., Valayannopoulos, V., Héron, D., Dorison, N., Mignot, C., Seta, N., Chantret, I., Dupré, T., Moore, S. E. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919849/ https://www.ncbi.nlm.nih.gov/pubmed/27343064 http://dx.doi.org/10.1186/s13023-016-0468-1 |
Ejemplares similares
-
Acetazolamide treatment in late onset CDG type 1 due to biallelic pathogenic DHDDS variants
por: Mousa, Jehan, et al.
Publicado: (2022) -
MAN1B1-CDG: Three new individuals and associated biochemical profiles
por: Sakhi, Soraya, et al.
Publicado: (2021) -
Identification of Roles for Peptide: N-Glycanase and Endo-β-N-Acetylglucosaminidase (Engase1p) during Protein N-Glycosylation in Human HepG2 Cells
por: Chantret, Isabelle, et al.
Publicado: (2010) -
Nutritional Therapies in Congenital Disorders of Glycosylation (CDG)
por: Witters, Peter, et al.
Publicado: (2017) -
Retinal Degeneration Caused by Rod-Specific Dhdds Ablation Occurs without Concomitant Inhibition of Protein N-Glycosylation
por: Ramachandra Rao, Sriganesh, et al.
Publicado: (2020)